Previous 10 | Next 10 |
The latest outbreak of monkeypox has some scratching their heads. What more can 2022 bring to the market? We’ve seen a stock market crash, the hopeful recovery from COVID-19, record inflation, rising rates, and now this. But it has placed some penny stocks in focus. On Wednes...
/C O R R E C T I O N -- Aethlon Medical, Inc./ PR Newswire In the news release, Aethlon Medical to Present at the H.C. Wainwright Global Investment Conference, issued 17-May-2022 by Aethlon Medical, Inc. over PR Newswire, we are advised by the company that in the "Co...
Gainers: Allarity Therapeutics (ALLR) +13%. Better Therapeutics (BTTX) +19%. GeoVax Labs GOVX +10%. Insulet PODD +7%. MDxHealth (MDXH) +5%. Losers: INmune Bio (INMB) -29%. Liquidia (LQDA) -21%. TherapeuticsMD (TXMD) -19%. Aethlon Medical (AEMD) -14%....
3 Penny Stocks to Add to Your Watchlist Right Now If you’re looking for the best penny stocks to buy, there are hundreds of options to choose from. And with a rather positive day of trading for penny stocks and blue chips , the market is ripe with opportunity. But, trading pe...
The latest virus captivating headlines in the stock market today is monkeypox. This has sent speculators searching for stocks with exposure to potential treatments. According to the CDC: “Because monkeypox virus is closely related to the virus that causes smallpox, the smallpox...
Aethlon Medical to Present at the H.C. Wainwright Global Investment Conference PR Newswire SAN DIEGO , May 17, 2022 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical technology company focused on developing products to diagnose and treat life and or...
Aethlon Medical Publishes In Vitro Studies Demonstrating Hemopurifier Resin Binding of Seven Clinically Relevant COVID-19 Variants PR Newswire Viral capture efficiency ranged from 53% to 89% for the seven COVID-19 variants tested SAN DIEGO , May 2, 2022 /...
Aethlon Medical, Inc. (AEMD) Q3 2022 Earnings Conference Call February 14, 2022 4:30 PM ET Company Participants Jim Frakes – Chief Financial Officer Chuck Fisher – Chief Executive Officer Steven LaRosa – Chief Medical Officer Conference Call Participants Marla Marin ...
Aethlon Medical press release (NASDAQ:AEMD): FQ3 GAAP EPS of -$0.16 misses by $0.02. Revenue of $0.02M (-96.8% Y/Y) misses by $0.19M. For further details see: Aethlon Medical GAAP EPS of -$0.16 misses by $0.02, revenue of $0.02M misses by $0.19M
AAP, AEMD, AMKR, ANET, ASYS, BKD, CAR, CIDM, CLR, OTCQB:ELTP, OTCQB:GAXY, HE, IBIO, KRG, MEDP, OMCL, OTTR, POWW, PRI, SCI, SRC, STEM, TNET, VNO, WTER, ZD For Seeking Alpha's full earnings season calendar, click here. For further details see: Notable earnings after Monday's close
News, Short Squeeze, Breakout and More Instantly...
2024-06-28 12:40:00 ET SAN DIEGO - June 28, 2024 (Investorideas.com Newswire) Aethlon Medical, Inc. ( Nasdaq: AEMD ), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, today reported financial results for its fiscal ye...
Aethlon Medical Announces Financial Results for the Fiscal Year Ended March 31, 2024 and Provides Corporate Update PR Newswire Conference Call to be Held Today at 4:30 p.m. ET SAN DIEGO , June 27, 2024 /PRNewswire/ -- Aethlon Medical, Inc. (Na...
DS Smith Plc. (DITHF) is expected to report for Q4 2024 Bluegreen Vacations Holding Corporation - Class B (BVHBB) is expected to report for Q1 2024 Harbour Energy Plc ADR (HBRIY) is expected to report for Q1 2024 Bayerische Motoren Werke AG (BAMXF) is expected to report for Q1 2024 ...